Industry Policy to Set the Market Free: Drug Pricing and the Factor (f) Program

Labour and Industry

Volumn 8, Issue 2, 1997, Pages 67-84

  Löfgren, Hans ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347219994     PISSN: 10301763     EISSN: 23255676     Source Type: Journal    
DOI: 10.1080/10301763.1997.10722008     Document Type: Article

References (43)

1. Anonymous managing director, interview with author, 6/9/1994.
2. APMA. 1977. Fact Bonk: The Prescription Medicine Industry in Australia Sydney: Australian Pharmaceutical Manufacturers Association.
3. APMA. 1988. Annual Report 198ft Sydney: Australian Pharmaceutical Manufacturers Association.
4. APMA. 1991. Submission by the Australian Pharmaceutical Manufacturers Association to the Bureau of Industry Economics Review of the Pharmaceutical Industry Development Program—Factor F.
5. APMA. 1993. Proposal for Reform of Pharmaceutical Benefits Scheme Pricing and Reimbursement Sydney: Australian Pharmaceutical Manufacturers Association.
6. APMA. 1994. Annual Report 1994 Sydney: Australian Pharmaceutical Manufacturers Association.
7. APMA. 1995. Submission No 31 Industry Commission Inquiry into the Pharmaceutical Industry.
8. Australian National Audit Office. 1993. Project Audit: Department of Industry, Technology and Regional Development Pharmaceutical Industry Development Program—The Factor f Scheme Canberra: AGPS.
9. Bell, K. 17/9/1994. interview with author
10. Bell, S. 1993. Australian Manufacturing and the State: The Politics of Industry Policy in the Post-War Era Cambridge: Cambridge University Press.
11. Bell, S. 1997. Ungoverning the Economy: The Political Economy of Australian Economic Policy Melbourne: Oxford University Press.
12. Bureau of Industry Economics. 1985. Retail Pharmacy in Australia: An Economic Appraisal Canberra: AGPS.
13. Bureau of Industry Economics. 1991. The Pharmaceutical Industry: Impediments and Opportunities Canberra: AGPS.
14. Button, J. 1992. Statement on the Pharmaceutical Industry, 31 March.
15. Button, J. 31/8/1994. interview with author
16. Button, J. and Blewett, N. 1987. Policies for the Development of the Pharmaceutical Pmducts Industry Joint media statement 115/87.
17. Button, J. and Blewett, N. 1988. Pharmaceutical Products Industry: Pricing Guidelines Joint media statement 79/88.
18. Capling, A. and Galligan, B. 1992. Beyond the Protective State: The Political Economy of Australia's Manufacturing Industry Policy Cambridge. Cambridge University Press.
19. Caruana, L. 1996. ‘Factor F Bugbears Run Riot in Parkville’. The Australian, 16 December: 24.
20. CSL Pharmaceuticals. 1995. Submission No 39 Industry Commission Inquiry into the Pharmaceutical Industry.
21. Cerny, P. G. 1997. ‘Paradoxes of the Competition State: The Dynamics of Political Globalization’. Government and Opposition, 32 (2): 251–274.
22. Department of Industry, Science and Technology. 1995. Submission No 56 Industry Commission Inquiry into the Pharmaceutical Industry.
23. Ewer, P. 1997. “ ‘Tariffs: Now What for Industry Policy?’ ”. In Frontline, No 44: 7, 14.
24. Hooper, N. 1994. ‘Industry Policy Approaches the Critical Stage’. Business Review Weekly, 28: 60–63. March:
25. Industries Assistance Commission. 1986. Pharmaceutical Products Canberra: AGPS.
26. Industry Commission. 1993. Transcript of proceedings at Canberra 9 December 1993 Inquiry into Research and Development.
27. Industry Commission. 1995. Transcripts of proceedings from round table discussion on prescription products in Sydney 16 August, 1995 Industry Commission Inquiry into the pharmaceutical industry.
28. Industry Commission. 1996a. The Pharmaceutical Industry Report No. 51 Canberra: AGPS.
29. Industry Commission. 1996b. Transcript of proceedings at Melbourne on Tuesday 20 February 1996 Inquiry into the Pharmaceutical Industry.
30. Jessop, B. 1994. “ ‘Changing Forms and Functions of the State in an Era of Globalization and Regionalization’ in ”. In The Political Economy of Diversity: Evolutionary Perspectives on Economic Order and Disorder Edited by: Delorme, R. and Dopfer, K. 102–125. Aldershot: Edward Elgar.
31. Johnston, M. A. 1990. Australia's Pharmaceutical Pricing Strategy Mich.: Ann Arbor. PhD thesis, Harvard University [, University Microfilm International[.
32. Lewis, S. 1996. A Lower Dose for Drug Companies'. Australian Financial Review, 18 February: 13.
33. Löfgren, H. 1996. ‘State Supremacy in Decline: The Pharmaceutical Industry and the Australian Government’. Journal of Industry Studies, 3 (1): 87–103.
34. Löfgren, H. 1997. Globalisation of the Pharmaceutical Industry and the Australian State: The Transformation of a Policy Network PhD thesis. Centre for Public Policy, University of Melbourne.
35. Merck, Sharpe Dohme. 1995. Submission No 27 Industry Commission Inquiry into the Pharmaceutical Industry.
36. Moore, J. 1997. New Policies Promote Investment in Australia's Pharmaceutical Industry Minister for Industry, Science and Tourism, Media release (87/97) 8 April 1997.
37. Parry, T G. and Creyke, P. 1991. The Australian Pharmaceutical Industry: Achievements. Prospects and the Policy Environment Sydney. Australian Pharmaceutical Manufacturers Association.
38. Pfizer. 1995. Submission No 70 Industry Commission Inquiry into the Pharmaceutical Industry.
39. Pharmaceutical Manufacturing Industry Inquiry [Ralph Inquiry[. 1979. Report Canberra: AGPS.
40. Porter, I. 1994. Australian Financial Review, 22 ‘Govt Incentive Pays Off for Glaxo’ September: 8.
41. Roberts, P. 1996. ‘Drug industry seeking coherent policy’. Australian Financial Review, 18 February: 25.
42. Sheehan, P. J., Pappas, N. and Cheng, E. 1994. The Rebirth of Australian Industry: Australian Trade in Elaborately Transformed Manufactures 1979–1993 Melbourne: Centre for Strategic Economic Studies, Victoria University.
43. Stevens, M. 1993. ‘Drug Exports Help to Cure Our Trade Ills’. Business Review Weekly, 12: 56–59. Feb: